Institute for Clinical & Economic Review Indefinitely Postpones Public Meetings for Sickle Cell Disease and Cystic Fibrosis
March 19, 2020
March 19, 2020
BOSTON, Massachusetts, March 19 -- The Institute for Clinical and Economic Review issued the following announcement:
* * *
- Expands Other Assessment Timelines Up to Three Months
* * *
The Institute for Clinical and Economic Review (ICER) announced several changes to its timelines for upcoming assessments. ICER's review process involves significant engagement across a variety of external stakeholders -- health care providers, life sciences . . .
* * *
- Expands Other Assessment Timelines Up to Three Months
* * *
The Institute for Clinical and Economic Review (ICER) announced several changes to its timelines for upcoming assessments. ICER's review process involves significant engagement across a variety of external stakeholders -- health care providers, life sciences . . .